Guobang Pharma Ltd. (605507.SS)
CNY 18.71
(-0.64%)
CNY 18.71
(-0.64%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.10 CNY | -33.33% |
| 2022 | 1.65 CNY | 30.95% |
| 2021 | 1.26 CNY | -13.1% |
| 2020 | 1.45 CNY | 64.77% |
| 2019 | 0.88 CNY | 100.0% |
| 2018 | 0.44 CNY | 18.92% |
| 2017 | 0.37 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.36 CNY | 63.64% |
| 2024 Q3 | 0.32 CNY | -13.51% |
| 2024 Q2 | 0.37 CNY | 2.78% |
| 2023 Q4 | 0.22 CNY | -8.33% |
| 2023 Q3 | 0.24 CNY | -17.24% |
| 2023 Q2 | 0.29 CNY | -17.14% |
| 2023 Q1 | 0.35 CNY | -2.78% |
| 2023 FY | - CNY | -33.33% |
| 2022 FY | - CNY | 30.95% |
| 2022 Q3 | 0.41 CNY | -22.64% |
| 2022 Q2 | 0.53 CNY | 47.22% |
| 2022 Q1 | 0.36 CNY | 9.09% |
| 2022 Q4 | 0.36 CNY | -12.2% |
| 2021 FY | - CNY | -13.1% |
| 2021 Q1 | 0.39 CNY | 8.33% |
| 2021 Q2 | 0.41 CNY | 5.13% |
| 2021 Q3 | 0.30 CNY | -26.83% |
| 2021 Q4 | 0.33 CNY | 10.0% |
| 2020 Q1 | 0.34 CNY | 0.0% |
| 2020 FY | - CNY | 64.77% |
| 2020 Q4 | 0.36 CNY | -10.0% |
| 2020 Q3 | 0.40 CNY | -33.33% |
| 2020 Q2 | 0.60 CNY | 76.47% |
| 2019 FY | - CNY | 100.0% |
| 2018 FY | - CNY | 18.92% |
| 2017 FY | - CNY | 0.0% |